Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

brunnings garden products pty ltd - dicamba present as the dimethylamine salt; mcpa present as the dimethylamine salt - soluble concentrate - dicamba present as the dimethylamine salt benzoic acid-arylaliphatic active 2.6 g/l; mcpa present as the dimethylamine salt phenoxy acids-mcpa-amine active 17.2 g/l - herbicide - lawn | turf - bindy-eye | capeweed | cat's ear or flatweed | clover | dandelion - taraxacum officinale | dock | plantain | ribwort, ribgrass or lamb's tongue | thistle | bindii | bogan flea | broadleaf dock | calotis hispidula | common dandelion | common plantain | curled dock | english dandelion | european dandelion | jo-jo | lambs tongue | narrow leaf plantain | onehunga weed | rumex brownii | rumex crispus | rumex obtusifolius | star burr | taraxacum spp. | true dandelion

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

brunnings garden products pty ltd - dicamba present as the dimethylamine salt; mcpa present as the dimethylamine salt - soluble concentrate - dicamba present as the dimethylamine salt benzoic acid-arylaliphatic active 3.5 g/l; mcpa present as the dimethylamine salt phenoxy acids-mcpa-amine active 23.0 g/l - herbicide - bent lawn or turf | buffalo grass lawn or turf | common couch lawn or turf | fescue lawn or turf | grass for turf or lawn | kiku - bindy-eye | capeweed | cat's ear or flatweed | clover | creeping oxalis | cudweed | fleabane | jo-jo | plantain | thistle | bindii | bindy-eye | bogan flea | calotis hispidula | clover sorrel | common plantain | dwarf jo-jo | hairy jo-jo | jo-jo | lambs tongue | onehunga | onehunga weed | small-leaved oxalis | soft bindy-eye | soliva anthemifolia | soliva sessilis | soliva spp. | star burr | wood sorrel (yellow) | yellow wood sorrel

New Zealand - English - Medsafe (Medicines Safety Authority)

max health limited - dobutamine hydrochloride 14 mg/ml equivalent to dobutamine 12.5 mg/ml, 250 mg dobutamine in 20 ml;   - concentrate for infusion - 12.5 mg/ml - active: dobutamine hydrochloride 14 mg/ml equivalent to dobutamine 12.5 mg/ml, 250 mg dobutamine in 20 ml   excipient: hydrochloric acid sodium metabisulfite water for injection - dobutamine hydrochloride is indicated when inotropic support is necessary for the treatment of patients with hypoperfusion states in whom cardiac output is insufficient to meet circulatory demands. dobutamine hydrochloride is also indicated when inotropic support is required for the treatment of patients in whom abnormally increased ventricular filling pressures introduce the risk of pulmonary congestion and oedema. conditions which may precipitate such situations include the following hypoperfusion states: initially cardiac in origin: a. acute heart failure acute myocardial infarction, cardiogenic shock, following cardiac surgery, medicine-induced depression of cardiac contractility such as that which occurs in excessive ?-adrenergic receptor blockade. b. chronic heart failure acute decompensation of chronic congestive heart failure, temporary inotropic support in advanced chronic congestive heart failure, as an adjunct to therapy with conventional oral inotropic agents, systemic vasodilators, and diuretics. initially noncardiac in origin: acute hypoperfusion states secondary to trauma, surgery, sepsis, or hypovolaemia when mean arterial pressure is above 70-mm hg and pulmonary capillary wedge pressure is 18-mm hg or greater, with inadequate response to volume repletion and increased ventricular filling pressure, low cardiac output secondary to mechanical ventilation with positive end-expiratory pressure (peep). paediatric population: dobutamine is indicated in all paediatric age groups (from neonates to 18 years of age) as inotropic support in low cardiac output hypoperfusion states resulting from decompensated heart failure, following cardiac surgery, cardiomyopathies and in cardiogenic or septic shock. dobutamine stress echocardiography: dobutamine hydrochloride may be used as a substitute for physical exercise in stress testing in the diagnosis of coronary artery disease. precautions apply (refer to data sheet).

Israel - English - Ministry of Health

novartis israel ltd - glyceryl trinitrate - patches - glyceryl trinitrate 25 mg/patch - glyceryl trinitrate - glyceryl trinitrate - prophylaxis of angina pectoris.

Israel - English - Ministry of Health

novartis israel ltd - glyceryl trinitrate - patches - glyceryl trinitrate 25 mg/patch - glyceryl trinitrate - glyceryl trinitrate - prophylaxis of angina pectoris.

Israel - English - Ministry of Health

novartis israel ltd - glyceryl trinitrate - patches - glyceryl trinitrate 50 mg/patch - glyceryl trinitrate - glyceryl trinitrate - prophylaxis of angina pectoris.

Israel - English - Ministry of Health

novartis israel ltd - glyceryl trinitrate - patches - glyceryl trinitrate 50 mg/patch - glyceryl trinitrate - glyceryl trinitrate - prophylaxis of angina pectoris.

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - verapamil hydrochloride - tablets - verapamil hydrochloride 40 mg - verapamil - verapamil - angina pectoris, cardiac arrhythmias, hypertension.

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - verapamil hydrochloride - tablets - verapamil hydrochloride 120 mg - verapamil - verapamil - angina pectoris, cardiac arrhythmias, hypertension.

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - verapamil hydrochloride - tablets slow release - verapamil hydrochloride 240 mg - verapamil - verapamil - mild to moderate hypertension. angina pectoris.